Document Detail


Current strategies for optimizing the use of cardiopulmonary bypass in neonates and infants.
MedLine Citation:
PMID:  12607719     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The use of cardiopulmonary bypass is still necessary for the repair of many congenital cardiac defects. However, exposure to cardiopulmonary bypass can still lead to major morbidity and sometimes mortality, especially in neonates and infants, despite a perfect surgical repair. Various research-based strategies have been used to minimize some of the complications related to cardiopulmonary bypass, including the systemic inflammatory response, hemodilution, and transfusion requirement. This overview provides some of the strategies that we use in our practice in applying cardiopulmonary bypass in the repair of congenital cardiac defects in neonates and infants.
Authors:
Irving Shen; Carmen Giacomuzzi; Ross M Ungerleider
Related Documents :
1352419 - Cryptorchidism in newborns with gastroschisis and omphalocele.
18972209 - Birth defects and genetic disorders among arab americans--michigan, 1992-2003.
1573689 - Neural tube defects in the middle belt of nigeria.
7556029 - Reproductive impairment in the florida panther: nature or nurture?
17917009 - Robert a. good, the march of dimes, and immunodeficiency: an historical perspective.
17689999 - Transient multiple acyl-coa dehydrogenation deficiency in a newborn female caused by ma...
11109139 - Healing madness and despair through meeting.
9164769 - Maternal and perinatal risk factors for later delinquency.
7771639 - Independent associations among maternal alcohol consumption and infant thyroxine levels...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  75     ISSN:  0003-4975     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  2003 Feb 
Date Detail:
Created Date:  2003-02-27     Completed Date:  2003-03-17     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S729-34     Citation Subset:  AIM; IM    
Affiliation:
Doernbecher Children's Hospital, Oregon Health & Science University, Portland, Oregon 97201, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aprotinin / therapeutic use
Cardiopulmonary Bypass* / instrumentation,  methods
Heart Arrest, Induced
Heart Defects, Congenital / surgery*
Hemostasis, Surgical
Hemostatics / therapeutic use
Humans
Infant
Infant, Newborn
Postoperative Period
Ultrafiltration
Chemical
Reg. No./Substance:
0/Hemostatics; 9087-70-1/Aprotinin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Therapy with insulin in cardiac surgery: controversies and possible solutions.
Next Document:  Aprotinin and preservation of myocardial function after ischemia-reperfusion injury.